相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overview of Humira® Biosimilars: Current European Landscape and Future Implications
Jill Coghlan et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018
Inmaculada Hernandez et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary
William B. Feldman et al.
JAMA INTERNAL MEDICINE (2020)
Utilization and treatment costs of tumor necrosis factor inhibitors after the introduction of biosimilar infliximab in the United States
Seoyoung C. Kim et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Uptake of Infliximab Biosimilars Among the Medicare Population
Alice J. Chen et al.
JAMA INTERNAL MEDICINE (2020)
The US Biosimilar Market: Stunted Growth and Possible Reforms
Ameet Sarpatwari et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare Population
Steven Kozlowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
The Impact of the Entry of Biosimilars: Evidence from Europe
Fiona M. Scott Morton et al.
REVIEW OF INDUSTRIAL ORGANIZATION (2018)
Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis
Steven Simoens et al.
PHARMACOECONOMICS (2017)
Progress and Hurdles for Follow-on Biologics
Ameet Sarpatwari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
分享论文
